AFTER VACCINE EFFORT PUT PRODUCTION ON HOLD, HORIZON CAN MANUFACTURE EYE DRUG AGAIN: The U.S. Food and Drug Administration has given Horizon Therapeutics authorization to manufacture more Tepezza drug ...
HEALTH PULSE EXCLUSIVE — Hearing loss lawsuits might be a dark cloud on Horizon's sale: Amid Horizon Therapeutics' pending $27.8 billion sale to Amgen, the Deerfield pharmaceutical company is facing a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback